Integra LifeSciences Holdings Management
Management criteria checks 3/4
Integra LifeSciences Holdings' CEO is Jan De Witte, appointed in Dec 2021, has a tenure of 2.92 years. total yearly compensation is $6.39M, comprised of 13.7% salary and 86.3% bonuses, including company stock and options. directly owns 0.031% of the company’s shares, worth €527.99K. The average tenure of the management team and the board of directors is 3.6 years and 11.5 years respectively.
Key information
Jan De Witte
Chief executive officer
US$6.4m
Total compensation
| CEO salary percentage | 13.7% |
| CEO tenure | 2.9yrs |
| CEO ownership | 0.03% |
| Management average tenure | 3.6yrs |
| Board average tenure | 11.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$7m |
| Jun 30 2024 | n/a | n/a | US$24m |
| Mar 31 2024 | n/a | n/a | US$40m |
| Dec 31 2023 | US$6m | US$875k | US$68m |
| Sep 30 2023 | n/a | n/a | US$101m |
| Jun 30 2023 | n/a | n/a | US$131m |
| Mar 31 2023 | n/a | n/a | US$172m |
| Dec 31 2022 | US$9m | US$850k | US$181m |
| Sep 30 2022 | n/a | n/a | US$173m |
| Jun 30 2022 | n/a | n/a | US$166m |
| Mar 31 2022 | n/a | n/a | US$157m |
| Dec 31 2021 | US$899k | US$59k | US$169m |
Compensation vs Market: Jan's total compensation ($USD6.39M) is above average for companies of similar size in the German market ($USD1.64M).
Compensation vs Earnings: Jan's compensation has been consistent with company performance over the past year.
CEO
Jan De Witte (60 yo)
2.9yrs
Tenure
US$6,388,756
Compensation
Mr. Jan De Witte has been President, Chief Executive Officer & Director of Integra LifeSciences Holdings Corporation since December 1, 2021. He had been the Chief Executive Officer at Barco NV since Septem...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 26.9yrs | US$422.52k | 2.27% € 38.7m | |
| President | 2.9yrs | US$6.39m | 0.031% € 528.0k | |
| Executive VP & CFO | 1.4yrs | US$1.67m | 0.054% € 926.3k | |
| Senior VP of Finance & Principal Accounting Officer | 7.1yrs | US$1.25m | 0.047% € 797.1k | |
| Executive VP | 6yrs | US$1.62m | 0.082% € 1.4m | |
| Executive VP & President of Tissue Technologies | 11.9yrs | US$1.42m | 0.084% € 1.4m | |
| Executive VP & President of Codman Specialty Surgical | 4.5yrs | US$2.83m | 0.075% € 1.3m | |
| Corporate VP of Global Operations & Supply Chain | 4.3yrs | no data | no data | |
| Vice President of Global Corporate Communications & Public Relations | no data | no data | no data | |
| Vice President of Global Marketing | no data | no data | no data | |
| Executive VP & Chief Human Resources Officer | 1.8yrs | no data | 0.032% € 538.4k | |
| Corporate VP & Chief Digital Officer | 2.8yrs | no data | no data |
3.6yrs
Average Tenure
57yo
Average Age
Experienced Management: IL3's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 26.9yrs | US$422.52k | 2.27% € 38.7m | |
| President | 2.9yrs | US$6.39m | 0.031% € 528.0k | |
| Independent Director | 15.6yrs | US$297.54k | 0.11% € 1.8m | |
| Independent Director | 18.8yrs | US$293.28k | 0.082% € 1.4m | |
| Independent Presiding Director | 11.5yrs | US$342.54k | 0.18% € 3.0m | |
| Independent Director | 32.8yrs | US$306.31k | 0.091% € 1.5m | |
| Independent Director | less than a year | US$90.68k | 0.016% € 275.9k | |
| Independent Director | 3.6yrs | US$260.04k | 0.028% € 484.2k | |
| Independent Director | 2.3yrs | US$297.54k | 0.021% € 356.7k |
11.5yrs
Average Tenure
63yo
Average Age
Experienced Board: IL3's board of directors are seasoned and experienced ( 11.5 years average tenure).